Testing Method Development and Validation for in Vitro Skin Irritation Testing (SIT) by Using Reconstructed Human Epidermis (RhE) Skin Equivalent - EPiTRI®

Yu-Chun Lin,Hui-Chun Hsu,Chiu-Hsing Lin,Cheng-Yi Wu,Wannhsin Chen,Huey-Min Lai
DOI: https://doi.org/10.1007/978-981-13-2447-5_2
2018-12-28
Abstract:Current regulatory requirements focus on assessment of acute irritation potential of chemicals and cosmetics in order to support risk management. A trend has been changed from in vivo to in vitro testing due to 3R (replacement, reduction, refinement) requirements has resulted from a recent animal testing ban in Taiwan. RhE (Reconstructed human Epidermis) models use normal human keratinocytes to form a multi-layered epidermis including a stratum corneum at the top, which function as a barrier. Some commercialized RhEs passed validation of skin irritation test (SIT) examined by ECVAM, but none of them are originated from Chinese heredity. Therefore, ITRI started a RhE project some years ago based on our long-term developed cell culture experiences, such as isolation of cells from human donors, cell expansion technology, and our own GTP/GMP qualified facilities. So far, a well differentiated and with reproducible barrier function epidermis named EPiTRI® has been reconstructed. We developed a protocol for EPiTRI® SIT in accordance to OECD TG 439. The protocol displays a result of sensitivity of 100%, specificity of 70%, and accuracy of 85% in international validation study. Thus, the human epidermal skin equivalent EPiTRI® can be provided as an in vitro model for evaluation of skin irritation and a reliable method has been developed accordingly.
What problem does this paper attempt to address?